Immuron (IMRN) Receivables - Net (2016 - 2026)
Immuron (IMRN) posted Receivables - Net of $1.3 million for Q3 2026, down 35.06% on a QoQ basis from $1.9 million in Q4 2025, and up 6521.68% year-over-year from $18883.7 in Q3 2025.
Analysis
Immuron (IMRN) Receivables - Net (2016 - 2026) Analysis & Trends
Immuron has reported Receivables - Net for 11 years, with the latest figure at $1.3 million in Q3 2026.
- On a quarterly basis, Receivables - Net rose 6521.68% year-over-year to $1.3 million in Q3 2026; TTM through Aug 2026 was $1.3 million, a 6521.68% increase from a year earlier, with the FY2026 full-year figure at $1.3 million, up 6521.68% from the prior year.
- Receivables - Net was $1.3 million for Q3 2026 at Immuron, down from $1.9 million in the prior quarter.
- The five-year high for Receivables - Net was $1.9 million in Q4 2025, with the low at $4174.2 in Q3 2023.
- Average Receivables - Net over 5 years is $604218.6, with a median of $448265.1 recorded in 2022.
- The sharpest annual moves came in 2023 and 2026: Receivables - Net tumbled 99.09% in 2023, then soared 6521.68% in 2026.
- Over 5 years, Receivables - Net stood at $435537.1 in 2022, then plunged by 37.61% to $271736.4 in 2023, then surged by 233.93% to $907412.5 in 2024, then soared by 112.21% to $1.9 million in 2025, then tumbled by 35.06% to $1.3 million in 2026.
- The last three Receivables - Net figures came in at $1.3 million (Q3 2026), $1.9 million (Q4 2025), and $18883.7 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 2, 2025 | 18,883.70 |
| Jun 30, 2025 | 1.23 Mn |
| Dec 31, 2024 | 907,412.52 |
| Sep 9, 2024 | 9,245.88 |
| Jun 30, 2024 | 914,444.58 |
| Dec 31, 2023 | 271,736.45 |
| Sep 28, 2023 | 273,610.37 |
| Aug 30, 2023 | 4,174.20 |
| Jun 30, 2023 | 278,987.02 |
| Dec 31, 2022 | 435,537.13 |
| Aug 31, 2022 | 460,993.04 |
| Jun 30, 2022 | 474,811.41 |
| Dec 31, 2021 | 245,011.57 |
| Sep 30, 2021 | 246,118.79 |
| Jun 30, 2021 | 257,742.85 |
| Dec 31, 2020 | 239,519.28 |
| Sep 1, 2020 | 327,689.00 |
| Jun 30, 2020 | 214,774.13 |